Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 3
1993 6
1994 7
1995 6
1996 9
1997 3
1999 7
2000 3
2001 7
2002 8
2003 4
2004 7
2005 10
2006 7
2007 13
2008 9
2009 12
2010 14
2011 5
2012 6
2013 10
2014 8
2015 9
2016 13
2017 9
2018 11
2019 10
2020 7
2021 11
2022 10
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Foreword.
Azulay JP. Azulay JP. Rev Neurol (Paris). 2022 May;178(5):405. doi: 10.1016/j.neurol.2022.05.001. Rev Neurol (Paris). 2022. PMID: 35649635 No abstract available.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: azulay jp. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Editorial.
Azulay JP. Azulay JP. Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):3. doi: 10.1016/j.neurol.2022.01.002. Rev Neurol (Paris). 2022. PMID: 35144757 No abstract available.
Éditorial.
Azulay JP, Tranchant C. Azulay JP, et al. Presse Med. 2017 Mar;46(2 Pt 1):174. doi: 10.1016/j.lpm.2017.02.001. Presse Med. 2017. PMID: 28325375 French. No abstract available.
Editorial.
Azulay JP. Azulay JP. Rev Neurol (Paris). 2019 Jan-Feb;175(1-2):1. doi: 10.1016/j.neurol.2019.01.001. Rev Neurol (Paris). 2019. PMID: 30770036 No abstract available.
[Editorial].
Azulay JP. Azulay JP. Rev Neurol (Paris). 2015 Jan;171(1):1. doi: 10.1016/j.neurol.2015.01.001. Rev Neurol (Paris). 2015. PMID: 25613142 French. No abstract available.
[Gait disorders - foreword].
Azulay JP, Defebvre L. Azulay JP, et al. Rev Neurol (Paris). 2010 Feb;166(2):141. doi: 10.1016/j.neurol.2009.08.003. Epub 2009 Oct 6. Rev Neurol (Paris). 2010. PMID: 19811799 French. No abstract available.
Foreword.
Azulay JP, Durif F, Vidailhet M, Tranchant C. Azulay JP, et al. Rev Neurol (Paris). 2018 Nov;174(9):579-580. doi: 10.1016/j.neurol.2018.10.001. Rev Neurol (Paris). 2018. PMID: 30343834 No abstract available.
Editorial.
Azulay JP. Azulay JP. Rev Neurol (Paris). 2017 Jan-Feb;173(1-2):1. doi: 10.1016/j.neurol.2017.01.396. Rev Neurol (Paris). 2017. PMID: 28212828 No abstract available.
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
Béreau M, Kibleur A, Servant M, Clément G, Dujardin K, Rolland AS, Wirth T, Lagha-Boukbiza O, Voirin J, Santin MDN, Hainque E, Grabli D, Comte A, Drapier S, Durif F, Marques A, Eusebio A, Azulay JP, Giordana C, Houeto JL, Jarraya B, Maltete D, Rascol O, Rouaud T, Tir M, Moreau C, Danaila T, Prange S, Tatu L, Tranchant C, Corvol JC, Devos D, Thobois S, Desmarets M, Anheim M. Béreau M, et al. Among authors: azulay jp. Brain. 2024 Feb 1;147(2):472-485. doi: 10.1093/brain/awad324. Brain. 2024. PMID: 37787488
235 results